Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

View:
Post by sparky6 on Apr 08, 2021 11:24pm

TopBroker

May I ask where you found this information?  It is very impressive if true and important for this board to know the origin.
Comment by Gbathat on Apr 08, 2021 11:29pm
PR last summer https://www.reuters.com/article/brief-promis-neurosciences-bc-neuroimmun/brief-promis-neurosciences-bc-neuroimmunology-announce-progress-on-development-of-antibody-test-for-covid-19-idUSFWN2DU06W 
Comment by Gbathat on Apr 08, 2021 11:31pm
Full PR link https://promisneurosciences.com/news/promis-neurosciences-and-collaborator-bc-neuroimmunology-announce-significant-progress-on-development-of-highly-accurate-antibody-test-for-covid-19/ 
Comment by Gbathat on Apr 09, 2021 12:13am
And the real question is why did TB post this old info now? My recollection is that TB's posts are often prescient and generally on the money, though a bit harsh at times with respect to PMN management. But there has been plenty to criticize, and the business world is not for the soft.
Comment by DavidKingCanada on Apr 09, 2021 9:56am
Not sure about TB but PMN is has a bright future. With the influx of New Investors and the search for a new CEO. Should be an interesting year and 2022 the way I see it will be excellent. Hoping for more great news and 0.05-0.07 by Years End.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities